Annexin A11 (ANXA11) (Middle Region) Peptid
ANXA11
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle Annexin A11 (ANXA11) Produkte
- Annexin A11 (ANXA11)
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- GAGYPPVPPG GFGQPPSAQQ PVPPYGMYPP PGGNPPSRMP SYPPYPGAPV
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- ANXA11 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Annexin A11 (ANXA11)
- Hintergrund
-
This gene encodes a member of the annexin family, a group of calcium-dependent phospholipid-binding proteins. Annexins have unique N-terminal domains and conserved C-terminal domains, which contain calcium-dependent phospholipid-binding sites. The encoded protein is a 56-kD antigen recognized by sera from patients with various autoimmune diseases. Several transcript variants encoding two different isoforms have been identified.
Alias Symbols: ANX11, CAP50
Protein Size: 505 - Gen-ID
- 311
- NCBI Accession
- NM_001157, NP_001148
- UniProt
- P50995
-
Sie sind hier:
